RATIONALE: The rewarding effects of alcohol have been attributed to interactions between opioid and dopaminergic system within the mesolimbic reward pathway. We have previously shown that ablation of β-arrestin 2 (Arrb2), a crucial regulator of μ-opioid receptor function, attenuates alcohol-induced hyperlocomotion and c-fos activation in the nucleus accumbens. OBJECTIVES: Here, we further investigated the role of Arrb2 in modulating alcohol-induced dopamine (DA) release and conditioned place preference (CPP). We also assessed the functional importance of Arrb2 for μ-opioid receptor surface expression and signaling following an acute alcohol challenge. METHODS: Alcohol-evoked (0.375, 0.75, and 1.5 g/kg intraperitoneally) DA release was measured by in vivo microdialysis in the shell of nucleus accumbens. Reward was assessed by the CPP paradigm. Receptor function was assessed by μ-receptor binding and [(35)S]GTP-γ-S autoradiography. RESULTS: In Arrb2 knockout mice accumbal DA levels reach maximum response at a lower dose compared to wild-type (wt) animals. In line with these results, Arrb2 knockout mice display increased CPP for alcohol as compared to wt mice. Finally, Arrb2 mutant mice display increased μ-opioid receptor signaling in the ventral and dorsal striatum and amygdala in response to a low dose of alcohol, indicating impaired desensitization mechanisms in these mice. CONCLUSIONS: Our results show that Arrb2 modulates the response to low doses of alcohol on various levels including μ-opioid receptor signaling, DA release, and reward. They also reveal a clear dissociation between the effects of Arrb2 on psychomotor and reward behaviors.
RATIONALE: The rewarding effects of alcohol have been attributed to interactions between opioid and dopaminergic system within the mesolimbic reward pathway. We have previously shown that ablation of β-arrestin 2 (Arrb2), a crucial regulator of μ-opioid receptor function, attenuates alcohol-induced hyperlocomotion and c-fos activation in the nucleus accumbens. OBJECTIVES: Here, we further investigated the role of Arrb2 in modulating alcohol-induced dopamine (DA) release and conditioned place preference (CPP). We also assessed the functional importance of Arrb2 for μ-opioid receptor surface expression and signaling following an acute alcohol challenge. METHODS:Alcohol-evoked (0.375, 0.75, and 1.5 g/kg intraperitoneally) DA release was measured by in vivo microdialysis in the shell of nucleus accumbens. Reward was assessed by the CPP paradigm. Receptor function was assessed by μ-receptor binding and [(35)S]GTP-γ-S autoradiography. RESULTS: In Arrb2 knockout mice accumbal DA levels reach maximum response at a lower dose compared to wild-type (wt) animals. In line with these results, Arrb2 knockout mice display increased CPP for alcohol as compared to wt mice. Finally, Arrb2 mutant mice display increased μ-opioid receptor signaling in the ventral and dorsal striatum and amygdala in response to a low dose of alcohol, indicating impaired desensitization mechanisms in these mice. CONCLUSIONS: Our results show that Arrb2 modulates the response to low doses of alcohol on various levels including μ-opioid receptor signaling, DA release, and reward. They also reveal a clear dissociation between the effects of Arrb2 on psychomotor and reward behaviors.
Authors: David W Oslin; Wade Berrettini; Henry R Kranzler; Helen Pettinati; Joel Gelernter; Joseph R Volpicelli; Charles P O'Brien Journal: Neuropsychopharmacology Date: 2003-06-18 Impact factor: 7.853
Authors: Laura M Bohn; Raul R Gainetdinov; Tatyana D Sotnikova; Ivan O Medvedev; Robert J Lefkowitz; Linda A Dykstra; Marc G Caron Journal: J Neurosci Date: 2003-11-12 Impact factor: 6.167
Authors: Kellie M Jaremko; Nicholas L Thompson; Beverly A S Reyes; Jay Jin; Brittany Ebersole; Christopher B Jenney; Patricia S Grigson; Robert Levenson; Wade H Berrettini; Elisabeth J Van Bockstaele Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2013-12-12 Impact factor: 5.067
Authors: Marcus W Meinhardt; Daniel C Sévin; Manuela L Klee; Sandra Dieter; Uwe Sauer; Wolfgang H Sommer Journal: Neuropsychopharmacology Date: 2015-03-13 Impact factor: 7.853
Authors: Derik Hermann; Natalie Hirth; Matthias Reimold; Anil Batra; Michael N Smolka; Sabine Hoffmann; Falk Kiefer; Hamid R Noori; Wolfgang H Sommer; Gerald Reischl; Christian la Fougère; Karl Mann; Rainer Spanagel; Anita C Hansson Journal: Neuropsychopharmacology Date: 2016-08-11 Impact factor: 7.853
Authors: Stefanie Grabrucker; Jasmin C Haderspeck; Ann Katrin Sauer; Nadine Kittelberger; Harun Asoglu; Alireza Abaei; Volker Rasche; Michael Schön; Tobias M Boeckers; Andreas M Grabrucker Journal: Front Mol Neurosci Date: 2018-01-15 Impact factor: 5.639
Authors: Nitish Mittal; Ani Minasyan; Nicole Romaneschi; Joshua K Hakimian; Gabriel Gonzalez-Fernandez; Ralph Albert; Nina Desai; Ian A Mendez; Timothy Schallert; Sean B Ostlund; Wendy Walwyn Journal: PLoS One Date: 2017-10-03 Impact factor: 3.240